NCT07446439 A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use Status RECRUITING Phase PHASE3
NCT06836557 Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis Status RECRUITING Phase PHASE3
NCT06804603 A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use Status COMPLETED Phase PHASE2
NCT06138613 Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05903924 Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness Status COMPLETED Phase PHASE3
NCT04849559 Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers Status COMPLETED Phase PHASE1/PHASE2
NCT04474990 Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis Status AVAILABLE Phase N/A
NCT04327661 Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness Status COMPLETED Phase PHASE3
NCT04326426 ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection Status ENROLLING_BY_INVITATION Phase PHASE3
NCT04140695 Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) Status TERMINATED Phase PHASE3
NCT04028492 Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis Status COMPLETED Phase PHASE3
NCT03772340 Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness Status COMPLETED Phase PHASE2
NCT03568331 Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE) Status COMPLETED Phase PHASE3
NCT02651714 Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02621385 Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects Status COMPLETED Phase PHASE1